Prevention of hepatitis C recurrence after liver transplantation: An update.

about

Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort.

P2860

Q40108499-BB62D2D1-95F7-4704-A6CF-C35B4B26B18B

P2860

Prevention of hepatitis C recurrence after liver transplantation: An update.

Item

http://www.wikidata.org/entity/Q36220172

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Prevention of hepatitis C recurrence after liver transplantation: An update.

@ast

Prevention of hepatitis C recurrence after liver transplantation: An update.

@en

type

Item

label

Prevention of hepatitis C recurrence after liver transplantation: An update.

@ast

Prevention of hepatitis C recurrence after liver transplantation: An update.

@en

prefLabel

Prevention of hepatitis C recurrence after liver transplantation: An update.

@ast

Prevention of hepatitis C recurrence after liver transplantation: An update.

@en

P1476

Prevention of hepatitis C recurrence after liver transplantation: An update.

@en

P2093

Ilaria Lenci

http://www.w3.org/2001/XMLSchema#string

Leonardo Baiocchi

http://www.w3.org/2001/XMLSchema#string

Marco Carbone

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive immunotherapy with liver allograft–derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

Diagnosis, management, and treatment of hepatitis C: an update

Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation

Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data.

P304

36-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4292/WJGPT.V3.I4.36

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230830985

http://www.w3.org/2001/XMLSchema#string

P698

22966482

http://www.w3.org/2001/XMLSchema#string

P932

3437445

http://www.w3.org/2001/XMLSchema#string

Prevention of hepatitis C recurrence after liver transplantation: An update.

about

P2860

P2860

Prevention of hepatitis C recurrence after liver transplantation: An update.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932